Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

AxyS Pharmaceuticals' APC-366 shows good antiasthmatic activity in phase IIa trial

May 1, 1998

New PDE IV inhibitors for asthma reported by Celltech

April 30, 1998

Astra obtains rights from Takeda to develop TxA2 antagonist

April 30, 1998

U.K. market introduction for long-acting, nonsedating antihistamine

April 29, 1998

Sepracor completes norastemizole trial; additional studies planned

April 29, 1998

Glaxo Wellcome launches Flovent for pediatric asthma in U.S.

April 28, 1998

Glaxo Wellcome seeks approval for combination asthma product

April 28, 1998

Bronchodilating and antiinflammatory agents claimed by Nikken

April 27, 1998

Montelukast shows promise in the treatment of pediatric asthma patients

April 27, 1998

Boehringer Ingelheim puts LTB4 antagonist on clinical testing track

April 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...